NCT07681596
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07681596
Title A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Research Site RECRUITING Duarte California 91010 United States Details
Research Site NOT_YET_RECRUITING Denver Colorado 80218 United States Details
Research Site NOT_YET_RECRUITING Tampa Florida 33612 United States Details
Research Site NOT_YET_RECRUITING Atlanta Georgia 30322 United States Details
Research Site NOT_YET_RECRUITING St Louis Missouri 63110 United States Details
Research Site NOT_YET_RECRUITING Hackensack New Jersey 07601 United States Details
Research Site NOT_YET_RECRUITING Cleveland Ohio 44195 United States Details
Research Site NOT_YET_RECRUITING Nashville Tennessee 37203 United States Details
Research Site NOT_YET_RECRUITING Houston Texas 77030 United States Details
Research Site NOT_YET_RECRUITING Milwaukee Wisconsin 53226 United States Details
Research Site NOT_YET_RECRUITING Camperdown 2050 Australia Details
Research Site RECRUITING East Melbourne 3002 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field